Development of an International Core Outcome Set for Best Care for the Dying Person

Background:
Outcome measurement is essential to progress clinical practice and improve patient care.

Aim:
To develop a Core Outcome Set for best care for the dying person.

Design:
We followed the Core Outcome Measures in Effectiveness Trials (COMET) Initiative guidelines, which involved identifying potential outcomes via a systematic literature review (n?=?619 papers) and from participants in the “iLIVE” project (10 countries: 101 patients, 37 family members, 63 clinicians), followed by a two-round Delphi study, and a consensus meeting.

Setting/participants:
Clinicians, researchers, family members, and patient representatives from 20 countries participated in the Delphi Rounds 1 (n?=?462) and 2 (n?=?355). Thirty-two participants attended the consensus meeting.

Results:
From the systematic review and the cohort study we identified 256 and 238 outcomes respectively, from which we extracted a 52-outcome list covering areas related to the patients’ physical, psychosocial, and spiritual dimensions, family support, place of care and care delivery, relational aspects of care, and general concepts. A preliminary 13-outcome list reached consensus during the Delphi. At the consensus meeting, a 14-item Core Outcome Set was ratified by the participants.

Conclusions:
This study involved a large and diverse sample of key stakeholders in defining the core outcome set for best care for the dying person, focusing on the last days of life. By actively integrating the perspectives of family carers and patient representatives from various cultural backgrounds this Core Outcome Set enriches our understanding of essential elements of care for the dying and provides a solid foundation for advancing quality of end-of-life care.

Contributors

Sofia C Zambrano, Martina Egloff, Valentina Gonzalez-Jaramillo, Andri Christen-Cevallos Rosero, Simon Allan, Pilar Barnestein-Fonseca, John Ellershaw, Claudia Fischer, Dagny Faksvåg Haugen, Urška Lunder, Marisa Martin-Rosello, Stephen Mason, Birgit Rasmussen, Valgerdur Sigurðardóttir, Judt Simon, Vilma A Tripodoro, Agnes van der Heide, Lia van Zuylen, Raymond Voltz, Carl Johan Fürst, Paula R Williamson, and Steffen Eychmüller on behalf of iLIVE

Publication

Journal: Palliative Medicine
Volume:
Issue:
Pages: -
Year: 2024
DOI: https://doi.org/10.1177/02692163241300867

Further Study Information

Current Stage: Completed
Date: January 2017 - February 2023
Funding source(s): The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: iLIVE is a project funded by the European Union’s Horizon 2020 Research and Innovation Program under Grant agreement no: 825731. The dissemination activities within the iLIVE project do not represent the opinion of the European Community and only reflect the opinion of the authors and/or the Consortium. SCZ was funded by the Swiss National Science Foundation (SNSF) via an Eccellenza Professorial Fellowship (grant number PCEFP1_194177).


Health Area

Disease Category: Other

Disease Name: Advanced cancer and advanced non-malignant illnesses, Palliative care

Target Population

Age Range: 18 - 100

Sex: Either

Nature of Intervention: Palliative

Stakeholders Involved

- Clinical experts
- Consumers (caregivers)
- Consumers (patients)
- Families
- Patient/ support group representatives
- Researchers
- Service providers
- Service users

Study Type

- COS for clinical trials or clinical research
- COS for practice

Method(s)

- Consensus meeting
- Delphi process
- Focus group(s)
- Interview
- Survey
- Systematic review

Q-sort interviews

The study will involve four stages for the development of a core outcome set.

Initially, a systematic review of the literature will identify the outcomes measured in existing peer reviewed literature, including interventional studies, observational studies, and qualitative studies. Grey literature and relevant national guidelines from different countries will be searched for.

A second stage will determine patient and proxy defined outcomes of care at the end of life through quantitative and qualitative methodologies (e.g. in-depth interviews, focus groups, q-sort interviews, questionnaires) with participants from these stakeholder groups. This step will be duplicated in several countries lead by members of the International Collaborative for Best Care for the Dying Person. Results from existing studies from the Collaborative will also be collated into the list of outcomes.

Thirdly, from a list of salient outcomes identified through stages 1 and 2, international experts, researchers, bereaved family members, and patients will be asked to rank the importance of the preselected outcomes in order to prioritise outcomes through a Delphi process.

Lastly, a face-to-face consensus meeting of international experts, researchers, family members, and patient/family representatives will take place in order to define, propose and endorse the core outcome set.